Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide adjunct therapy after first islet cell transplantation in type 1 diabetes
2009-013090-18Phase 2Terminated
- Sponsor
- Novo Nordisk
- Start
- Jul 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Victoza + standard care with Placebo + standard care (2 arms). Started Jul 2010; status: terminated.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2009-013090-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013090-18.